Stay updated on Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error page; its footer revision identifier changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T15:08:38.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A banner was added announcing that NIH is transitioning to using “Super Intelligence” instead of “Artificial Intelligence” and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:56:58.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:21:16.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site revision number in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:12:52.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content and navigation. This blocks access to the study details from the page.
    Difference
    17%
    Check dated 2026-09-20T22:38:38.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, indicating a new revision of the page.
    Difference
    0.1%
    Check dated 2026-08-30T22:00:56.000Z thumbnail image

Stay in the know with updates to Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.